LINDSAY CLARKE: Open Payments
NPI 1174963854 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 14 payments from 10 companies in 2025. Trend: 2023 $281 · 2024 $293 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $64 |
| Galderma Laboratories, L.P. | 3 | $54 |
| ABBVIE INC. | 2 | $46 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| LNHC, Inc | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
Products named: Bimzelx, RINVOQ, Zoryve, TREMFYA, Sotyktu, SKYRIZI, NEMLUVIO, COSENTYX.
Industry payments across NC — which companies pay providers there.
